NCT02946931View on ClinicalTrials.gov

All-Case Surveillance of Prizbind®

CompletedOBSERVATIONAL
Enrollment

1,402

Participants

Timeline

Start Date

November 18, 2016

Primary Completion Date

November 3, 2020

Study Completion Date

November 3, 2020

Conditions
Hemorrhage
Interventions
DRUG

Prizbind®

Prizbind®

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02946931 - All-Case Surveillance of Prizbind® | Biotech Hunter | Biotech Hunter